Malaria chemoprophylaxis for long-term travellers and expatriates;Malariaprofylakse til langtidsrejsende og udstationerede

Ugeskrift for Laeger

Volumn 167, Issue 42, 2005, Pages 3988-3992

  Kurtzhals, Jørgen A L ^a   Vestergaard, Lasse S ^b  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; DOXYCYCLINE; MEFLOQUINE; PROGUANIL; VIBRADOX; ANTIMALARIAL AGENT; ATOVAQUONE; CHLOROQUINE; NAPHTHOQUINONE;

DRUG COST; FEAR; HEALTH CARE ACCESS; HUMAN; INFECTION RISK; LONG TERM CARE; MALARIA; MALARIA CONTROL; MOSQUITO; PATIENT COMPLIANCE; SHORT SURVEY; TRAVEL; ARTICLE; COUNSELING; DRUG COMBINATION; INSECT BITE; RISK ASSESSMENT; RISK FACTOR;

ANTIMALARIALS; ATOVAQUONE; CHLOROGUANIDE; CHLOROQUINE; COUNSELING; DOXYCYCLINE; DRUG COMBINATIONS; HUMANS; INSECT BITES AND STINGS; MALARIA; MEFLOQUINE; MOSQUITO CONTROL; NAPHTHOQUINONES; RISK ASSESSMENT; RISK FACTORS; TRAVEL;

EID: 26944479349     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. Andersen, P. Vaccinationsforslag ved udlandsrejse, del I og del II. EPI-Nyt 2005, uge 23 A+B.
2. Bouchaud O, Cot M, Kony S et al. Do African immigrants living in France have long-term malarial immunity? Am J Trop Med Hyg 2005;72:21-5.
3. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. The Cochrane Database of Systematic Reviews 2004, Issue 2. Art. NO.: CD000363, pub 2. DOI: 10.1002/14651858.CD000363.pub2.
4. Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med 2002;347:13-8.
5. Costantini C, Badolo A, Ilboudo-Sanogo E. Field evaluation of the efficacy and persistence of insect repellents DEET, IR3535, and KBR 3023 against Anopheles gambiae complex and other Afrotropical vector mosquitoes. Trans R Soc Trop Med Hyg 2004;98:644-52.
6. Held TK, Weinke T, Mansmann U et al. Malaria prophylaxis: identifying risk groups for non-compliance. Q J Med 1994;87:17-22.
7. Schlagenhauf P, Tschopp A, Johnson R et al. Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study. BMJ 2003;327:1078.
8. Klement E, Chauveheid MP, Thellier M et al. Subacute clinical forms of Plasmodium falciparum malaria in travelers receiving chloroquine-proguanil prophylaxis. Clin Infect Dis 2001;33:e1-e2.
9. Petersen E. The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults. J Travel Med 2003;10(suppl 1):S13-S15.
10. Croft AM, Garner P. Mefloquine for preventing malaria in non-immune adult travellers. The Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD000138. DOI: 10.1002/14651858.CD000138.
11. World Health Organisation. International Travel and Health. 2005. www.who.int/ith/august 2005.
12. Schalgenhauf-Lawlor P, Funk-Baumann M. PDQ Travelers' malaria. Ontario: B C Decker Inc., 2005